Clinical Trials Directory

Trials / Unknown

UnknownNCT03045562

Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI

Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute ST Segment Elevation Myocardial Infarction After Primary PCI

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
536 (estimated)
Sponsor
Green Valley Group of China · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate the influence of Salvianolate injection on myocardial microcirculation perfusion in subjects with STEMI who underwent primary PCI

Detailed description

This is a prospective, randomized, double-blind and controlled study.536 subjects of STEMI who underwent primary PCI within the first 12 hours will be enrolled.all patients were assigned to receive 300mg of asprin and ≥300mg of clopidogrel as loading dose,and following 100mg and 75mg once daily respectively.Patients were assigned to receive Salvianolate injection or 0.9% sodium chloride injection in catherter room setting,and following similar medicine once daily respectively for 7 days.Myocardial circulation perfusion will be checked with mmediate coronary angiography parameters,ECG,echocardiographic,CK-MB.The major adverse cardiovascular events will be observed.

Conditions

Interventions

TypeNameDescription
DRUGNormal salinePatients will be assigned to receive 100ml of normal saline in catherter room setting,and following similar medicine once daily for 7 days.
DRUGSalvianolate injectionPatients will be assigned to receive Salvianolate injection dissolved in 100ml of normal saline in catherter room setting,and following similar medicine once daily for 7 days.

Timeline

Start date
2017-01-20
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2017-02-07
Last updated
2017-02-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03045562. Inclusion in this directory is not an endorsement.